Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
52.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Health Catalyst
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Medicaid Cuts Will Constrict Deals But Spur Efficiency
Key Takeaways Ongoing client budget cuts and cautious spending habits are limiting revenue growth and reducing average revenue per customer, stalling expansion from existing clients. Strategic focus on efficiency and shifting toward higher-margin technology may improve profitability, but could further constrain top-line growth and heighten volatility.
View narrative
US$3.00
FV
0% overvalued
intrinsic discount
0.091%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Energy Vault Holdings
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Declining Battery Storage Costs And Lithium Competition Will Threaten Margins
Key Takeaways Rapid advances and falling costs in competing battery storage threaten demand, margins, and long-term revenue for Energy Vault's gravity-based systems. Dependence on large projects and persistent supply chain, permitting, and economic risks could cause delays, unpredictability, and lower-than-expected profitability.
View narrative
US$0.50
FV
202.0% overvalued
intrinsic discount
118.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Yatsen Holding
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
China's Aging Population And Rising Costs Will Constrain Profitability
Key Takeaways Shifting demographics, economic headwinds, and intensifying competition threaten revenue stability and long-term growth for Yatsen's core brands. Increasing regulatory pressures and changing consumer trends drive up compliance, marketing, and R&D costs, squeezing margins and profitability.
View narrative
US$3.44
FV
161.0% overvalued
intrinsic discount
21.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Backblaze
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Concentrated AI Markets Will Squeeze Margins But Enable Resilience
Key Takeaways Heavy reliance on a few large AI-driven customers and intense competition from major cloud providers create risks for revenue stability and margin pressure. Expansion into international and premium markets offers growth, but increasing regulatory demands could raise compliance costs and limit profitability gains.
View narrative
US$8.00
FV
5.6% undervalued
intrinsic discount
15.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
8x8
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Microsoft And Cisco Will Intensify Pricing And Compliance Pressures
Key Takeaways Intensifying competition and lack of product differentiation threaten market share, pricing power, and customer retention, keeping growth below peers. Rising compliance and marketing costs are squeezing margins and delaying the path to sustained profitability.
View narrative
US$1.50
FV
26.7% overvalued
intrinsic discount
-0.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Euroapi
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Rising Regulatory And Geopolitical Risks Will Undermine API Profits
Key Takeaways Intensifying regulatory pressures and global deglobalization trends threaten profitability and export-driven growth, especially amid shifting mandates for local drug production. Heavy reliance on a few key clients and shrinking demand for traditional APIs expose the company to heightened revenue volatility and margin pressure.
View narrative
€2.50
FV
26.2% overvalued
intrinsic discount
-2.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Personalis
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Delays And Scrutiny Will Limit Revenue But Enable Future Adaptation
Key Takeaways Growing demand for precision medicine drives long-term opportunity, but delayed pharma projects and reimbursement challenges threaten near-term revenue stability and margin expansion. Intensifying competition, regulatory pressures, and persistent operating losses risk constraining profitability and may force cost cuts or future shareholder dilution.
View narrative
US$5.00
FV
3.0% undervalued
intrinsic discount
17.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
GoHealth
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Rising Medicare Uncertainties Will Press Margins But Stability Will Emerge
Key Takeaways Exposure to regulatory shifts and the rise of digital insurance platforms may threaten GoHealth's revenue stability and erode its core business. Persistent high customer acquisition costs, margin pressures, and volatile carrier dynamics could undermine sustainable earnings improvement.
View narrative
US$16.00
FV
64.4% undervalued
intrinsic discount
5.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Blade Air Mobility
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Delays Will Slow Organ Transport Yet Offer Future Value
Key Takeaways Heavy dependence on organ transport growth and uncertain regulatory or technological adoption pose risks to revenue stability and margin expansion. Delays in eVTOL adoption or high fixed costs could constrain cost savings, while integration and environmental challenges may hamper long-term profit growth.
View narrative
US$5.00
FV
16.6% undervalued
intrinsic discount
7.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies